View ValuationCanmax Technologies 将来の成長Future 基準チェック /06現在、 Canmax Technologiesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長29.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 31Canmax Technologies Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Canmax Technologies Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Mar 19Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu Chinaお知らせ • Dec 31Canmax Technologies Co., Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026Canmax Technologies Co., Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026お知らせ • Sep 30Canmax Technologies Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025Canmax Technologies Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025お知らせ • Jul 02Canmax Technologies Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Canmax Technologies Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025お知らせ • Apr 25Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu Chinaお知らせ • Mar 31Canmax Technologies Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Canmax Technologies Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Dec 31Canmax Technologies Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Canmax Technologies Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥30.72, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years.New Risk • Oct 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 123% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 110% Cash payout ratio: 140% Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin).Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.53 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.53 in 3Q 2023). Revenue: CN¥1.74b (down 23% from 3Q 2023). Net income: CN¥88.4m (down 80% from 3Q 2023). Profit margin: 5.1% (down from 20% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥23.56, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 71% over the past three years.お知らせ • Sep 30Canmax Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024Canmax Technologies Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 29%After last week's 29% share price gain to CN¥20.57, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years.Reported Earnings • Aug 07First half 2024 earnings released: EPS: CN¥1.00 (vs CN¥1.65 in 1H 2023)First half 2024 results: EPS: CN¥1.00 (down from CN¥1.65 in 1H 2023). Revenue: CN¥3.71b (down 44% from 1H 2023). Net income: CN¥834.9m (down 39% from 1H 2023). Profit margin: 23% (up from 21% in 1H 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Jul 01Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to CN¥17.36. The fair value is estimated to be CN¥23.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period.お知らせ • Jun 29Canmax Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 07, 2024Canmax Technologies Co., Ltd. announced that they will report first half, 2024 results on Aug 07, 2024Buy Or Sell Opportunity • Jun 19Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to CN¥18.59. The fair value is estimated to be CN¥23.40, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period.お知らせ • Apr 24Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu ChinaReported Earnings • Apr 24Full year 2023 earnings released: EPS: CN¥1.99 (vs CN¥8.63 in FY 2022)Full year 2023 results: EPS: CN¥1.99 (down from CN¥8.63 in FY 2022). Revenue: CN¥10.5b (down 39% from FY 2022). Net income: CN¥1.66b (down 75% from FY 2022). Profit margin: 16% (down from 39% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Apr 20Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to CN¥19.12. The fair value is estimated to be CN¥24.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years.お知らせ • Mar 30Canmax Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024Canmax Technologies Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024Buy Or Sell Opportunity • Mar 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 23% to CN¥19.56. The fair value is estimated to be CN¥24.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years.New Risk • Mar 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 29% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 29% per year for the foreseeable future. High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Profit margins are more than 30% lower than last year (24% net profit margin).New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (24% net profit margin).Buy Or Sell Opportunity • Feb 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 31% to CN¥18.19. The fair value is estimated to be CN¥23.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥19.03, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past three years.お知らせ • Dec 29Canmax Technologies Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024Canmax Technologies Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024お知らせ • Nov 11Canmax Technologies Co., Ltd. (SZSE:300390) announces an Equity Buyback for CNY 250 million worth of its shares.Canmax Technologies Co., Ltd. (SZSE:300390) announces a share repurchase program. Under the program, the company will repurchase CNY 250 million worth of its shares. The shares will be repurchased at a price of not more than CNY 39.5 per share. The shares purchased will be used for ESOP and equity incentives. The program is valid for 12 months.Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥2.15 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.53 (down from CN¥2.15 in 3Q 2022). Revenue: CN¥2.27b (down 53% from 3Q 2022). Net income: CN¥447.1m (down 73% from 3Q 2022). Profit margin: 20% (down from 34% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.59 (vs CN¥2.61 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.59 (down from CN¥2.61 in 2Q 2022). Revenue: CN¥3.10b (down 29% from 2Q 2022). Net income: CN¥493.1m (down 75% from 2Q 2022). Profit margin: 16% (down from 45% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Upcoming Dividend • Apr 28Upcoming dividend of CN¥2.00 per share at 4.1% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 4.1%. Within top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.9%).Reported Earnings • Mar 30Full year 2022 earnings released: EPS: CN¥11.22 (vs CN¥1.59 in FY 2021)Full year 2022 results: EPS: CN¥11.22 (up from CN¥1.59 in FY 2021). Revenue: CN¥17.0b (up 401% from FY 2021). Net income: CN¥6.59b (up CN¥5.68b from FY 2021). Profit margin: 39% (up from 27% in FY 2021). The increase in margin was driven by higher revenue.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥2.79 (vs CN¥0.41 in 3Q 2021)Third quarter 2022 results: EPS: CN¥2.79 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥4.80b (up 439% from 3Q 2021). Net income: CN¥1.64b (up CN¥1.41b from 3Q 2021). Profit margin: 34% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue.Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥3.40 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥3.40 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥4.39b (up 475% from 2Q 2021). Net income: CN¥1.99b (up CN¥1.83b from 2Q 2021). Profit margin: 45% (up from 22% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 41%, compared to a 39% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥96.49, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 96% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥59.44 per share.Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥69.91, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 54% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.47 per share.Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥2.60 (vs CN¥0.27 in 1Q 2021)First quarter 2022 results: EPS: CN¥2.60 (up from CN¥0.27 in 1Q 2021). Revenue: CN¥3.39b (up 407% from 1Q 2021). Net income: CN¥1.52b (up CN¥1.37b from 1Q 2021). Profit margin: 45% (up from 22% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 100%, compared to a 43% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥73.59, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Luxury industry in China. Total returns to shareholders of 170% over the past year.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥77.00, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Luxury industry in China. Total returns to shareholders of 177% over the past year.Reported Earnings • Feb 09Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: CN¥1.59 (up from CN¥0.52 in FY 2020). Revenue: CN¥3.40b (up 159% from FY 2020). Net income: CN¥910.7m (up 218% from FY 2020). Profit margin: 27% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 96%, compared to a 32% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥73.98, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 16x in the Luxury industry in China. Total returns to shareholders of 177% over the past year.Reported Earnings • Oct 14Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.08 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥890.7m (up 195% from 3Q 2020). Net income: CN¥237.7m (up 465% from 3Q 2020). Profit margin: 27% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Aug 01Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.24 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥763.4m (up 44% from 2Q 2020). Net income: CN¥166.5m (up 19% from 2Q 2020). Profit margin: 22% (down from 26% in 2Q 2020). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥34.67, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 19x in the Luxury industry in China.Reported Earnings • Apr 21First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.09 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥668.0m (up 188% from 1Q 2020). Net income: CN¥146.1m (up 208% from 1Q 2020). Profit margin: 22% (up from 21% in 1Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥32.26, the stock trades at a forward P/E ratio of 69x. Average forward P/E is 18x in the Luxury industry in China.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.95, the stock is trading at a trailing P/E ratio of 66.5x, up from the previous P/E ratio of 57.4x. This compares to an average P/E of 26x in the Luxury industry in China.Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improved over the past weekAfter last week's 27% share price gain to CN¥31.16, the stock is trading at a trailing P/E ratio of 71.6x, up from the previous P/E ratio of 56.2x. This compares to an average P/E of 25x in the Luxury industry in China.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥22.28, the stock is trading at a trailing P/E ratio of 51.2x, up from the previous P/E ratio of 42.5x. This compares to an average P/E of 30x in the Luxury industry in China. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Canmax Technologies は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測XSEC:300390 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20269,0611,309-669-54N/A12/31/20257,549402-3,679-322N/A9/30/20256,7262-2,137927N/A6/30/20256,353-98-2,0511,028N/A3/31/20256,542393-2,634417N/A12/31/20246,6088348581,465N/A9/30/20247,0107615941,623N/A6/30/20247,5391,1207812,211N/A3/31/20248,6841,2802,7584,609N/A12/31/202310,4681,6591,8034,172N/A9/30/202313,3683,2529483,582N/A6/30/202315,8974,4492,2514,876N/A3/31/202317,1805,9492,9345,482N/A1/1/202317,0306,5864,5316,394N/A9/30/202213,6495,5155,5136,864N/A6/30/20229,7424,1103,2104,438N/A3/31/20226,1172,2833611,324N/A1/1/20223,398911-636180N/A9/30/20212,571607-859-219N/A6/30/20211,983411-308-46N/A3/31/20211,7493851120N/A12/31/20201,313286262350N/A9/30/20201,282242301387N/A6/30/20201,168222306385N/A3/31/202081797192277N/A12/31/201975862N/A147N/A9/30/201973663N/A165N/A6/30/201975258N/A173N/A3/31/201978155N/A139N/A12/31/201877850N/A118N/A9/30/201879047N/A117N/A6/30/201877740N/A106N/A3/31/201874633N/A99N/A12/31/201773632N/A88N/A9/30/201770919N/A39N/A6/30/201767717N/A28N/A3/31/201763618N/A21N/A12/31/201659116N/A22N/A9/30/201653732N/A50N/A6/30/201648535N/A45N/A3/31/201646141N/A54N/A12/31/201546047N/A54N/A9/30/201543647N/A44N/A6/30/201542946N/A27N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 300390の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 300390の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 300390の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 300390の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 300390の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 300390の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/18 11:46終値2026/05/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Canmax Technologies Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Yi ShiHaitong International Research LimitedBin LiHuatai ResearchZu Xue QiuIndustrial Securities Co. Ltd.
お知らせ • Mar 31Canmax Technologies Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Canmax Technologies Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Mar 19Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026Canmax Technologies Co., Ltd., Annual General Meeting, Apr 09, 2026, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China
お知らせ • Dec 31Canmax Technologies Co., Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026Canmax Technologies Co., Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026
お知らせ • Sep 30Canmax Technologies Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025Canmax Technologies Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025
お知らせ • Jul 02Canmax Technologies Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Canmax Technologies Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
お知らせ • Apr 25Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025Canmax Technologies Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China
お知らせ • Mar 31Canmax Technologies Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Canmax Technologies Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Dec 31Canmax Technologies Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Canmax Technologies Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥30.72, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years.
New Risk • Oct 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 123% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 110% Cash payout ratio: 140% Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin).
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.53 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.53 in 3Q 2023). Revenue: CN¥1.74b (down 23% from 3Q 2023). Net income: CN¥88.4m (down 80% from 3Q 2023). Profit margin: 5.1% (down from 20% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥23.56, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 71% over the past three years.
お知らせ • Sep 30Canmax Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024Canmax Technologies Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 29%After last week's 29% share price gain to CN¥20.57, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years.
Reported Earnings • Aug 07First half 2024 earnings released: EPS: CN¥1.00 (vs CN¥1.65 in 1H 2023)First half 2024 results: EPS: CN¥1.00 (down from CN¥1.65 in 1H 2023). Revenue: CN¥3.71b (down 44% from 1H 2023). Net income: CN¥834.9m (down 39% from 1H 2023). Profit margin: 23% (up from 21% in 1H 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Jul 01Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to CN¥17.36. The fair value is estimated to be CN¥23.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period.
お知らせ • Jun 29Canmax Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 07, 2024Canmax Technologies Co., Ltd. announced that they will report first half, 2024 results on Aug 07, 2024
Buy Or Sell Opportunity • Jun 19Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to CN¥18.59. The fair value is estimated to be CN¥23.40, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 62% over the last 3 years. Earnings per share has grown by 52%. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period.
お知らせ • Apr 24Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024Canmax Technologies Co., Ltd., Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: 3F, No. 99, Shuangma Street, Suzhou Industrial Park, Suzhou, Jiangsu China
Reported Earnings • Apr 24Full year 2023 earnings released: EPS: CN¥1.99 (vs CN¥8.63 in FY 2022)Full year 2023 results: EPS: CN¥1.99 (down from CN¥8.63 in FY 2022). Revenue: CN¥10.5b (down 39% from FY 2022). Net income: CN¥1.66b (down 75% from FY 2022). Profit margin: 16% (down from 39% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Apr 20Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to CN¥19.12. The fair value is estimated to be CN¥24.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years.
お知らせ • Mar 30Canmax Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024Canmax Technologies Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024
Buy Or Sell Opportunity • Mar 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 23% to CN¥19.56. The fair value is estimated to be CN¥24.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%. Revenue is forecast to decline by 2.4% in 2 years. Earnings are forecast to decline by 55% in the next 2 years.
New Risk • Mar 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 29% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 29% per year for the foreseeable future. High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Profit margins are more than 30% lower than last year (24% net profit margin).
New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Dividend is not well covered by cash flows (136% cash payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (24% net profit margin).
Buy Or Sell Opportunity • Feb 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 31% to CN¥18.19. The fair value is estimated to be CN¥23.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 76% over the last 3 years. Earnings per share has grown by 74%.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥19.03, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past three years.
お知らせ • Dec 29Canmax Technologies Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024Canmax Technologies Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024
お知らせ • Nov 11Canmax Technologies Co., Ltd. (SZSE:300390) announces an Equity Buyback for CNY 250 million worth of its shares.Canmax Technologies Co., Ltd. (SZSE:300390) announces a share repurchase program. Under the program, the company will repurchase CNY 250 million worth of its shares. The shares will be repurchased at a price of not more than CNY 39.5 per share. The shares purchased will be used for ESOP and equity incentives. The program is valid for 12 months.
Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥2.15 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.53 (down from CN¥2.15 in 3Q 2022). Revenue: CN¥2.27b (down 53% from 3Q 2022). Net income: CN¥447.1m (down 73% from 3Q 2022). Profit margin: 20% (down from 34% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.59 (vs CN¥2.61 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.59 (down from CN¥2.61 in 2Q 2022). Revenue: CN¥3.10b (down 29% from 2Q 2022). Net income: CN¥493.1m (down 75% from 2Q 2022). Profit margin: 16% (down from 45% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Upcoming Dividend • Apr 28Upcoming dividend of CN¥2.00 per share at 4.1% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 4.1%. Within top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.9%).
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: CN¥11.22 (vs CN¥1.59 in FY 2021)Full year 2022 results: EPS: CN¥11.22 (up from CN¥1.59 in FY 2021). Revenue: CN¥17.0b (up 401% from FY 2021). Net income: CN¥6.59b (up CN¥5.68b from FY 2021). Profit margin: 39% (up from 27% in FY 2021). The increase in margin was driven by higher revenue.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥2.79 (vs CN¥0.41 in 3Q 2021)Third quarter 2022 results: EPS: CN¥2.79 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥4.80b (up 439% from 3Q 2021). Net income: CN¥1.64b (up CN¥1.41b from 3Q 2021). Profit margin: 34% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥3.40 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥3.40 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥4.39b (up 475% from 2Q 2021). Net income: CN¥1.99b (up CN¥1.83b from 2Q 2021). Profit margin: 45% (up from 22% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 41%, compared to a 39% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥96.49, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 96% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥59.44 per share.
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥69.91, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 54% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.47 per share.
Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥2.60 (vs CN¥0.27 in 1Q 2021)First quarter 2022 results: EPS: CN¥2.60 (up from CN¥0.27 in 1Q 2021). Revenue: CN¥3.39b (up 407% from 1Q 2021). Net income: CN¥1.52b (up CN¥1.37b from 1Q 2021). Profit margin: 45% (up from 22% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 100%, compared to a 43% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥73.59, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Luxury industry in China. Total returns to shareholders of 170% over the past year.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥77.00, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Luxury industry in China. Total returns to shareholders of 177% over the past year.
Reported Earnings • Feb 09Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: CN¥1.59 (up from CN¥0.52 in FY 2020). Revenue: CN¥3.40b (up 159% from FY 2020). Net income: CN¥910.7m (up 218% from FY 2020). Profit margin: 27% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 96%, compared to a 32% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥73.98, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 16x in the Luxury industry in China. Total returns to shareholders of 177% over the past year.
Reported Earnings • Oct 14Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.08 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥890.7m (up 195% from 3Q 2020). Net income: CN¥237.7m (up 465% from 3Q 2020). Profit margin: 27% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 01Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.24 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥763.4m (up 44% from 2Q 2020). Net income: CN¥166.5m (up 19% from 2Q 2020). Profit margin: 22% (down from 26% in 2Q 2020). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥34.67, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 19x in the Luxury industry in China.
Reported Earnings • Apr 21First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.09 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥668.0m (up 188% from 1Q 2020). Net income: CN¥146.1m (up 208% from 1Q 2020). Profit margin: 22% (up from 21% in 1Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥32.26, the stock trades at a forward P/E ratio of 69x. Average forward P/E is 18x in the Luxury industry in China.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.95, the stock is trading at a trailing P/E ratio of 66.5x, up from the previous P/E ratio of 57.4x. This compares to an average P/E of 26x in the Luxury industry in China.
Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improved over the past weekAfter last week's 27% share price gain to CN¥31.16, the stock is trading at a trailing P/E ratio of 71.6x, up from the previous P/E ratio of 56.2x. This compares to an average P/E of 25x in the Luxury industry in China.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥22.28, the stock is trading at a trailing P/E ratio of 51.2x, up from the previous P/E ratio of 42.5x. This compares to an average P/E of 30x in the Luxury industry in China.